Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liujun Anwei
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Liujun Anwei is a traditional Chinese medicine (TCM) herbal formula used primarily for gastrointestinal disorders. It is a multi-herb combination designed to strengthen the spleen and stomach, harmonize the middle burner (digestive system), and alleviate symptoms such as poor appetite, bloating, nausea, and indigestion. The formula typically contains herbs like Codonopsis pilosula (Dang Shen), Atractylodes macrocephala (Bai Zhu), Poria cocos (Fu Ling), Glycyrrhiza uralensis (Gan Cao), Pinellia ternata (Ban Xia), Citrus reticulata peel (Chen Pi), among others. Its mechanism of action involves modulation of inflammatory pathways and regulation of digestive function through multiple targets; network pharmacology studies suggest involvement with targets such as AKT1, TP53, TNF-alpha, and IL-17 signaling pathways[1]. It is not a single pharmaceutical compound but rather a complex mixture characteristic of TCM practice.
- Brand names
- Liujun Anwei
- Other names
- Liujun Anwei decoctionLiujun Wan六君安胃六君子安胃
02
Targets
TP53 (Cellular Tumor Antigen p53 R175H)IL-17R (Interleukin 17 Receptor)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Liujun Anwei.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liujun Anwei.